Comment on FR Doc # 2026-08550, NRC-2025-0379-0011, from AMPERA, Inc.
AMPERA, Inc.SupportBusiness
Summary: AMPERA, Inc., a company developing subcritical microreactor technology, supports the proposed Part 57 rule as a framework for rapid licensing and high-volume deployment. They request specific revisions to ensure the rule is technology-inclusive for externally driven subcritical systems, provides a performance-based approach for material limits, and streamlines manufacturing license pathways.
Please see the attached file with comments on the proposed rule and guidance.